In vivo Imaging of HIV Pathogenesis
National Institute of Allergy and Infectious Diseases, Bethesda
POST: A post-doctoral position is available at the Division of Clinical Research of NIAID. The position will be based in our SPECT/CT imaging laboratory in Poolesville, MD, with periodic visits to our offices in Bethesda, MD.
JOB DESCRIPTION: The fellow will be involved in studies of in vivo imaging of HIV pathogenesis using Simian Immunodeficiency Virus (SIV) infected nonhuman primates, and will work in an interdisciplinary research team of immunologists, imagers, radiochemists, veterinarians and mathematicians. The successful candidate will receive training in the following areas: hplc analysis, cell culture and viral replication assays, cell binding assays, autoradiography, SPECT imaging, animal technical procedures including anesthesia preparation and recovery for imaging sessions, and treatment and medication under the direction of NIH veterinary staff.
REQUIREMENTS: Applicants should have a Ph.D, M.D., or D.V.M. degree with a background in infectious diseases research, pathology, imaging or virology.
· Candidates are expected to have less than 5 years of postdoctoral experience since receipt of their most recent degree.
· Previous training or experience in working in nuclear medicine imaging studies or nonhuman primate infectious diseases studies is desirable but not required.
· Must possess a license to drive since public transportation to our laboratory at the NIH Animal Center is not available.
Additional details about post-doctoral appointments at NIH can be found in this link https://www.training.nih.gov/programs/postdoc_irp
TO APPLY:Candidates should send a cover letter, CV including bibliography and contact information for three references to:
Michele Di Mascio, PhD
Division of Clinical Research
National Institute of Allergy and Infectious Diseases
6700 A, Rockledge Drive
Room 5130, Bethesda, MD, 20892
BB: 301-793-2785
Office: 301-451-5135
Fax: 301-480-0912
Email - mdimascio@niaid.nih.gov
No comments:
Post a Comment